Effectiveness and safety of darolutamide as a component of combination therapy in patients with prostate cancer

B. Ya. Alekseev; V. M. Perepukhov; K. M. Nyushko

Cancer Urology
Onkourologiâ

ISSN 1726-9776 (Print)
ISSN 1996-1812 (Online)

User

eng | рус

Cancer Urology

Advanced search

Archives

Download this PDF file

Fullscreen

For citations:

Alekseev B.Ya., Perepukhov V.M., Nyushko K.M. Effectiveness and safety of darolutamide as a component of combination therapy in patients with prostate cancer. Cancer Urology. 2023;19(4):167-175. (In Russ.) https://doi.org/10.17650/1726-9776-2023-19-4-167-175

Views PDF (Rus): 409

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 1726-9776 (Print)
ISSN 1996-1812 (Online)

* not an advertisement

Indexing Databases

* not an advertisement

Popular articles

Editor-in-Chief

Boris Ya. Alekseev

About the Authors

B. Ya. Alekseev
National Medical Research Radiological Center, Ministry of Health of Russia; Medical Institute of Continuing Education, Russian Biotechnological University
Russian Federation

3 2^nd Botkinskiy Proezd, Moscow 125284,

11 Volokolamskoe Shosse, Moscow 125080

V. M. Perepukhov
National Medical Research Radiological Center, Ministry of Health of Russia
Russian Federation

3 2^nd Botkinskiy Proezd, Moscow 125284

K. M. Nyushko
National Medical Research Radiological Center, Ministry of Health of Russia; Medical Institute of Continuing Education, Russian Biotechnological University
Russian Federation

Kirill M. Nyushko

3 2^nd Botkinskiy Proezd, Moscow 125284,

11 Volokolamskoe Shosse, Moscow 125080

Notifications

Article Tools

Finding References

Email this article (Login required)

Email the author (Login required)

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

Cancer Urology

For citations:

Cookies policy